Medicine that Causes Memory Loss: Risk of Neurocognitive Disorders
Journal Title: International Neuropsychiatric Disease Journal - Year 2016, Vol 8, Issue 1
Abstract
Medicine is one of the outstanding gifts of science to save lives. In addition to the desired therapeutic effect almost all of the medicine possesses the undesired secondary effect called side effect. From the over-the-counter (OTC) aspirin to the prescription medicine on the market, all medicines come with side effects. Numerous are negligible, few are problematic, some are major and certain are just weird. Almost any drug can cause nausea, vomiting or an upset stomach. Every medication carries some risks, although in some cases side effects are not noticeable as a result of sub-therapeutic concentration and memory loss are very common side effect of commonly used and prescribed medicines. The memory loss is one of the prominent causes of neurocognitive disorders, especially dementia, which is characterized by a disturbance of multiple brain functions, including memory, thinking, learning, reading calculation and judgment severe enough to reduce a person's ability to perform everyday activities. In addition to memory loss various factors as well as disorders contribute to the development of dementia. Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia. Including AD, Lewy body dementia and frontotemporal dementia give rise to progressive and irreversible loss of neurons and brain functions. At present, there are no treatments for these progressive neurodegenerative disorders. Medication associated with the risk of memory loss must be taken with more precaution. Therefore, the objective of this study is to show the risk of memory loss associated with antianxiety drugs (benzodiazepines), hypolipidemic drugs (statins), antiepileptic drugs (older and newer), antidepressant drugs (tricyclic antidepressants), narcotic painkillers (opioids), anti-Parkinson's drugs (dopamine agonists), antihypertension drugs (β-blockers), sleeping aids (nonbenzodiazepine sedative-hypnotics), incontinence drugs (anticholinergics and antimuscarinic) and antihistamines (first-generation).
Authors and Affiliations
Md. Sahab Uddin, Abdullah Al Mamun, Nilufa Haque Chaity, Anamul Haque, Nahia Akter
Keywords
Related Articles
- EP ID EP241745
- DOI 10.9734/INDJ/2016/26317
- Views 152
- Downloads 0
The use of Nutraceuticals as Mono- or Adjuvant Therapy to Pharmacotherapies in Major Depressive Disorder
Objectives: The present review provides an overview of the appropriate literature on the use of nutraceuticals in depression. The goal was to examine whether nutraceuticals, in combination with the current pharmacotherap...
Magnitude of Attention Deficit Hyper Kinetic Disorder among School Children of Mysore City
Background: Attention Deficit Hyperkinetic Disorder (ADHD) is a highly prevalent disorder of Childhood and adolescence. There are only a few studies reporting the prevalence of this condition. Methods: This cross-section...
Black Holes in Brain- Is There Any Relationship between Carotid Artery Plaque Type and Cerebral Micro Bleed? - Cohort from Pakistan
Purpose of Study: The purpose of this study is to correlate the presence of chronic micro bleed, patient symptoms, number of chronic micro bleeds and carotid plaque characteristics. Materials and Methods: Seventy consecu...
Pediatric Neurologic Disorders at a Tertiary Healthcare Facility in North-Central Nigeria: A 5 Year Review
Background: Neurologic disorders in children are common occurrences in clinical practice; they constitute a major cause of morbidity and disability in childhood. Children with neurologic disorders in developing countries...
Socio-demographic and Clinical Predictors of Co-morbid Psychiatric Disorders in Patients with Epilepsy
Background: Association between epilepsy and psychiatry has a long history that required a comprehensive care of patients with epilepsy. This would include special attention to the psychological and social consequences b...